LAVA Therapeutics NV Proceeds from Stock Options Exercised
LAVA Therapeutics NV reported Proceeds from Stock Options Exercised of $27.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2025-11-06
- LAVA Therapeutics NV proceeds from stock options exercised for the quarter ending 2024-12-31 was $2.00K.
- LAVA Therapeutics NV proceeds from stock options exercised for the quarter ending 2024-09-30 was $1.00K.
- LAVA Therapeutics NV proceeds from stock options exercised for the quarter ending 2024-06-30 was $16.00K.
- LAVA Therapeutics NV proceeds from stock options exercised for the quarter ending 2024-03-31 was $8.00K.
- LAVA Therapeutics NV proceeds from stock options exercised for fiscal 2024 was $27.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2024-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $3.00K derived: sum of 2 quarters · filed 2025-11-06 | $19.00K derived: sum of 3 quarters · filed 2025-11-06 | $27.00K 10-K · filed 2025-03-28 |
| 2024-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $17.00K derived: sum of 2 quarters · filed 2025-11-06 | $25.00K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $24.00K 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $8.00K 10-Q · filed 2025-05-14 |